Mylan expands nationwide recall for blood pressure medication

(FDA)

WICHITA, Kan. (KWCH/CBS) Mylan Pharmaceuticals is expanding their voluntary recall of some blood pressure medications after detecting trace amounts of a chemical linked to cancer.

Valsartan is indicated to address high blood pressure for treating heart failure and to decrease cardiovascular mortality following myocardial infarction.

This an expansion of a recall from two weeks ago of the blood blood pressure medication. The pills contain trace amounts of the chemical N-nitrosodiethylamine (NDEA).

The medications were distributed in the U.S. between March 2017 and November 2018.

The FDA encourages people who take the drug to talk with their pharmacist or physician about alternative treatments.